NCT02081001 - PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

September 30, 2014

Conditions

Hypoglycemia

Interventions

DRUG

Novo Nordisk GlucaGen®

single subcutaneous infusion doses at 0.3 μg/kg, 1.2 μg/kg and 2.0 μg/kg

DRUG

G-Pump™ (glucagon infusion)

single subcutaneous infusion doses at 0.3 μg/kg, 1.2 μg/kg and 2.0 μg/kg

Trial Locations (1)

Oregon Health & Science University, Portland